SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Centocor ( CNTO )
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
965 13 0 CNTO
Emcee:  PawPr Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
115 $34 as a support was tested and validated again. Nice move up for CNTO today. Thean-6/6/1997
114 Bruce: THANKS for the info and your comments. From a TA perspective, it appeaFNS-6/3/1997
113 Phase II results are to be announced at an international rheumatology meeting iPawPr-6/3/1997
112 Bruce: Do you know date and place of rheumatology meeting? Stock seems to be FNS-6/3/1997
111 I wouldn't want to be short the stock if they report positive TNF antibody PawPr-6/3/1997
110 Organ: I respect your opinion and you may be right! But here's my scenariFNS-5/31/1997
109 I must disagree. I think we are much more likely to see 30 again before 40. Aorgan-5/31/1997
108 Nice recovery today for CNTO. The $34 support held today. BGEN also moved up Thean-5/30/1997
107 Thean Y., THANKS for the info link on Celltech. Not surprised that they could FNS-5/28/1997
106 British biotech firm has a compound they believe will compete with CenTNF. ReaThean-5/28/1997
105 Thean Y.: AGREED! Close of $34 last Friday and 'breakout' today is inFNS-5/27/1997
104 We finally have gotten a nice breakout above $34 today. Look forwards to $38 sThean-5/27/1997
103 Those were Phase III trials, and the company has filed for expanded indicationsPawPr-5/23/1997
102 Nice volume (2.5 M shares) and up 2 today...a close above 34 tomorrow looks proFNS-5/23/1997
101 To anyone who can help! In doing research for CNTO for acedemic purposes, I seJoe Howard-5/22/1997
100 Great news about CenTNF. I believe CenTNF is real money in the bucket for CNTOThean-5/12/1997
99 I hope you're right about Reopro; don't forget they'll eventually bPawPr-5/4/1997
98 I think you're wrong about Reopro and anti-TNF. First, Reopro dying out? YoMac S. Giballa-5/2/1997
97 The big payoff will come if it can be shown that anti-TNF is a potent antiinflaPawPr-5/2/1997
96 Phil: <<My friend will probably not know who is actually getting the druFNS-4/30/1997
95 Phase III trials, as you know, are usually blindied as well as randomized. phil-4/30/1997
94 Phil, what did your friend say about CenTNF's efficacy in the treatment of Thean-4/29/1997
93 An interesting conversation. I dined with a colleague last night who is undertphil-4/29/1997
92 That doesn't count check the balance sheet, footnotes in 10-k, and tell me Dabo-4/25/1997
91 Thean, GREAT Job! Can't wait to see how next QTR goes....maybe CNTO can beFNS-4/23/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News